drugset / Trial / NCT02070133
Efficacy of Simvastatin for the Treatment of COPD
Phase 3
Completed
18 enrolled
Hospital Universitari Son Dureta
Cimera · collabFundació d'investigació Sanitària de les Illes Balears · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate in patients with stable Chronic Obstructive Pulmonary Disease (COPD) the efficacy of statins (simvastatin) on: (1) endothelial function; (2) systemic inflammation; (3)BODE (B: body mass , O: bronchial obstruction, D: dyspnea and, E: exercise tolerance) index; (4) Uric acid; and, (5)vascular growth factors. Design: a 12 weeks randomized (1:1), double-blind, placebo control study. Population: 18 males with stable COPD between 40-80 years of age, exsmokers, with Forced expiratory volume in one second (FEV1) between 30 and 80% predicted post-bronchodilation.
Timeline
- Start
- 2009-05
- Primary completion
- 2013-03
- Completion
- 2013-05
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Simvastatin | Small molecule | 40 mg | — |